[email protected]
CAS 98834-08-3 MORPHOLIN-4-YL-PIPERAZIN-1-YL-METHANONE molecular structure lightbox
CAS RN: 98834-08-3

MORPHOLIN-4-YL-PIPERAZIN-1-YL-METHANONE

  • Product code: SSC-212847
GET A QUOTE
Verified Factory Data

Supply Overview & Packaging Options

Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.

  • Pack sizes on record: 0.1g, 0.25g, 1g
  • Available purity: >95%
  • Inventory rows with stock: 3
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Available Pack Sizes & Stock

Specific stock quantities are shown below. Price is not displayed online and is confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 98834-08-3
Pack Size Recorded Purity Available Qty Ship From Inquiry
0.1g >95% 2 In Stock Shanghai Inquiry
0.25g >95% 2 In Stock Hong Kong Inquiry
1g >95% 2 In Stock Beijing Inquiry

98834-08-3 / morpholin-4-yl(piperazin-1-yl)methanone

Standard CAS: 98834-08-3 Multi CAS: Yes
Basic Information Computed Properties

Basic Information

CAS
98834-08-3
Multi CAS
Yes
Molecular Formula
C9H17N3O2
Molecular Weight
199.250000
Exact Mass
199.132077
InChI
InChI=1S/C9H17N3O2/c13-9(11-3-1-10-2-4-11)12-5-7-14-8-6-12/h10H,1-8H2
InChIKey
QRFWUPFGDJAVNO-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
14
Fraction Csp3
0.89
H-bond acceptors
3
H-bond donors
1
Molar refractivity
52.23
TPSA
44.81

LogP / Solubility

WLOGP
-0.66
MLOGP
-0.58
XLogP3
-1.3
Consensus LogP
-0.85
Log S (ESOL)
-0.66
Class (ESOL)
Very soluble
Log S (Ali)
-0.72
Class (Ali)
Very soluble
Log S (SILICOS-IT)
-0.41
Class (SILICOS-IT)
Very soluble

ADME

GI absorption
Low
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.4

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5

Customers Also Viewed

Get In Touch

Contact Us